Combinations and uses of PI3K inhibitors and endocrine therapy drugs
TW202637127APending Publication Date: 2026-09-16GUANGZHOU JOYO PHARMATECH CO LTD +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114148226
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-10
- Filing Date
- 2025-12-09
- Publication Date
- 2026-09-16
Smart Images
Figure TWG2TA001076688_001 
Figure TWG2TA001076688_002 
Figure TWG2TA001076688_003
Abstract
This disclosure relates to a combination of a PI3K inhibitor and an endocrine therapy agent, and its use therein. Specifically, this disclosure relates to a combination of a PI3K inhibitor and an endocrine therapy agent, and its use in the treatment of breast cancer, wherein the PI3K inhibitor is compound 1 or a pharmaceutically acceptable salt thereof.
Need to check novelty before this filing date? Find Prior Art